Edition:
United Kingdom

Bioblast Pharma Ltd (ORPN.OQ)

ORPN.OQ on NASDAQ Stock Exchange Capital Market

2.15USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$2.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
42,604
52-wk High
$5.99
52-wk Low
$1.64

Chart for

About

Bioblast Pharma Ltd (BioBlast) is an Israel-based development-stage biopharmaceutical company. The Company is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $7.39
Shares Outstanding(Mil.): 3.34
Dividend: --
Yield (%): --

Financials

  ORPN.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -3.67 -- --
ROI: -119.23 1.58 14.38
ROE: -119.23 2.41 16.07

BRIEF-Bioblast Pharma reports Q3 loss per share $0.32

* Bioblast Pharma reports third quarter 2017 financial results

02 Nov 2017

Earnings vs. Estimates